Caracterización del sistema de quorum sensing en Acinetobacter baumannii y su influencia en la motilidad y en la formación de biopelícula

Acinetobacter baumannii es un importante patógeno nosocomial Gram-negativo de especial interés debido a su habilidad para generar multirresistencias a antibióticos y a su formidable capacidad de supervivencia en forma de biopelículas, causando un gran número de infecciones humanas. Entre los mecanismos de virulencia de A. baumannii, destacan la motilidad y la formación de biopelícula, fenotipos controlados mediante una red compleja de factores donde se encuentra el sistema de comunicación bacteriano dependiente de la densidad celular denominado Quorum Sensing (QS), que está mediado por señales acil homoserín lactonas (AHLs). Diversos estudios han indicado la influencia del QS en Acinetobacter, sin embargo, el papel exacto que desempeña en estos fenotipos y los mecanismos que controlan la producción de AHLs todavía estaban por determinar. En este trabajo, por lo tanto, se caracterizó el sistema de QS de A. baumannii ATCC17978 y se analizó su influencia sobre la motilidad y la producción de biopelícula

Use of Quorum Sensing Inhibition Strategies to Control Microfouling

Interfering with the quorum sensing bacterial communication systems has been proposed as a promising strategy to control bacterial biofilm formation, a key process in biofouling development. Appropriate in vitro biofilm-forming bacteria models are needed to establish screening methods for innovative anti-biofilm and anti-microfouling compounds. Four marine strains, two Pseudoalteromonas spp. and two Vibrio spp., were selected and studied with regard to their biofilm-forming capacity and sensitivity to quorum sensing (QS) inhibitors. Biofilm experiments were performed using two biofilm cultivation and quantification methods: the xCELLigence® system, which allows online monitoring of biofilm formation, and the active attachment model, which allows refreshment of the culture medium to obtain a strong biofilm that can be quantified with standard staining methods. Although all selected strains produced acyl-homoserine-lactone (AHL) QS signals, only the P. flavipulchra biofilm, measured with both quantification systems, was significantly reduced with the addition of the AHL-lactonase Aii20J without a significant effect on planktonic growth. Two-species biofilms containing P. flavipulchra were also affected by the addition of Aii20J, indicating an influence on the target bacterial strain as well as an indirect effect on the co-cultured bacterium. The use of xCELLigence® is proposed as a time-saving method to quantify biofilm formation and search for eco-friendly anti-microfouling compounds based on quorum sensing inhibition (QSI) strategies. The results obtained from these two in vitro biofilm formation methods revealed important differences in the response of biosensor bacteria to culture medium and conditions, indicating that several strains should be used simultaneously for screening purposes and the cultivation conditions should be carefully optimized for each specific purposeThis work was supported by the European project BYEFOULING “Low-toxic cost-efficient environment-friendly antifouling materials” (FP7-OCEAN-2013 612717) and the project PID2019-104439RB-C21/AEI/10.13039/501100011033 of the Agencia Estatal de Investigación (AEI, Spain), and co-funded by the European Regional Development Fund of the European Union: A Way to Making Europe (FEDER). A.M. and A.P. were supported by predoctoral fellowships from the Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia (ED481A-2015/311 and ED481A-2019/194). C.M. was supported by a postdoctoral fellowship from Xunta de Galicia (IN606B-2019/010)S

Multiple quorum quenching enzymes are active in the nosocomial pathogen acinetobacter baumannii ATCC17978

Acinetobacter baumannii presents a typical luxI/luxR quorum sensing (QS) system (abaI/abaR) but the acyl-homoserine lactone (AHL) signal profile and factors controlling the production of QS signals in this species have not been determined yet. A very complex AHL profile was identified for A. baumannii ATCC17978 as well as for A. nosocomialis M2, but only when cultivated under static conditions, suggesting that surface or cell-to-cell contact is involved in the activation of the QS genes. The analysis of A. baumanni clinical isolates revealed a strain-specific AHL profile that was also affected by nutrient availability. The concentration of OHC12-HSL, the major AHL found in A. baumannii ATCC17978, peaked upon stationary-phase establishment and decreases steeply afterwards. Quorum quenching (QQ) activity was found in the cell extracts of A. baumannii ATCC17978, correlating with the disappearance of the AHLs from the culture media, indicating that AHL concentration may be self-regulated in this pathogen. Since QQ activity was observed in strains in which AidA, a novel α/β-hydrolase recently identified in A. baumannii, is not present, we have searched for additional QQ enzymes in A. baumannii ATCC17978. Seven putative AHL-lactonase sequences could be identified in the genome and the QQ activity of 3 of them could be confirmed. At least six of these lactonase sequences are also present in all clinical isolates as well as in A. nosocomialis M2. Surface-associated motility and biofilm formation could be blocked by the exogenous addition of the wide spectrum QQ enzyme Aii20J. The differential regulation of the QQ enzymes in A. baumannii ATCC17978 and the full dependence of important virulence factors on the QS system provides a strong evidence of the importance of the AHL-mediated QS/QQ network in this speciesS

Evaluation of the anti-fouling efficacy of bacillus licheniformis extracts under environmental and natural conditions

There is an increasing interest in developing innovative coatings and testing natural products with anti-fouling activity to substitute current highly toxic biocides that have a harmful impact on marine organisms. Bacillus licheniformis species have shown different anti-biofilm and anti-fouling activities in vitro, but so far, its efficacy in field trials has not been tested. For this purpose, the capacity of different extracts of B. licheniformis NCTC 10341T to prevent micro and macro-fouling was first tested in vitro. The methanol cell extract (MCE) inhibited bacterial biofilm formation without significantly affecting planktonic growth and displayed a significant efficacy to prevent larval settlement of the macro-fouler Bugula neritina in vitro without inducing lethality. Additionally, the MCE presented low toxicity against the non-target species Artemia salina. The B. licheniformis MCE was then incorporated in a self-polishing paint at 2 and 5% w/w and tested in a static immersion experiment in the Gulf of Aqaba (northern Red Sea) for 180 days. Fouling coverage decreased by 30% in the 5% MCE-treated panels in comparison with the control panels. Differences in the anti-biofilm activity of the extracts depending on the culture medium highlight the importance of the strict control of culture conditions for the production of biomass with stable bioactive activity. The results indicate the potential of B. licheniformis NCTC 10341T crude extracts for environmentally friendly anti-fouling applications, although a deeper characterization of the bioactive compounds present in the B. licheniformis MCE and its mode of action is required to allow strict control of the activity of the extracts to achieve large-scale industrial productionThis work was supported by the European Union under Grant FP7-OCEAN-2013 612717 (Low-toxic cost-efficient environment-friendly anti-fouling materials). AM was supported by a predoctoral fellowship from the Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia (ED481A-2015/311). CM was supported by a post-doctoral fellowship from Xunta de Galicia (IN606B-2019/010)S

Why Employees Do Bad Things: Moral Disengagement And Unethical Organizational Behavior

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90243/1/j.1744-6570.2011.01237.x.pd

Clinical applications of robotic technology in vascular and endovascular surgery

BackgroundEmerging robotic technologies are increasingly being used by surgical disciplines to facilitate and improve performance of minimally invasive surgery. Robot-assisted intervention has recently been introduced into the field of vascular surgery to potentially enhance laparoscopic vascular and endovascular capabilities. The objective of this study was to review the current status of clinical robotic applications in vascular surgery.MethodsA systematic literature search was performed in order to identify all published clinical studies related to robotic implementation in vascular intervention. Web-based search engines were searched using the keywords “surgical robotics,” “robotic surgery,” “robotics,” “computer assisted surgery,” and “vascular surgery” or “endovascular” for articles published between January 1990 and November 2009. An evaluation and critical overview of these studies is reported. In addition, an analysis and discussion of supporting evidence for robotic computer-enhanced telemanipulation systems in relation to their applications in laparoscopic vascular and endovascular surgery was undertaken.ResultsSeventeen articles reporting on clinical applications of robotics in laparoscopic vascular and endovascular surgery were detected. They were either case reports or retrospective patient series and prospective studies reporting laparoscopic vascular and endovascular treatments for patients using robotic technology. Minimal comparative clinical evidence to evaluate the advantages of robot-assisted vascular procedures was identified. Robot-assisted laparoscopic aortic procedures have been reported by several studies with satisfactory results. Furthermore, the use of robotic technology as a sole modality for abdominal aortic aneurysm repair and expansion of its applications to splenic and renal artery aneurysm reconstruction have been described. Robotically steerable endovascular catheter systems have potential advantages over conventional catheterization systems. Promising results from applications in cardiac interventions and preclinical studies have urged their use in vascular surgery. Although successful applications in endovascular repair of abdominal aortic aneurysm and lower extremity arterial disease have been reported, published clinical experience with the endovascular robot is limited.ConclusionsRobotic technology may enhance vascular surgical techniques given preclinical evidence and early clinical reports. Further clinical studies are required to quantify its advantages over conventional treatments and define its role in vascular and endovascular surgery

Preparation and certification of IRMM-1000a (20 mg) and IRMM-1000b (50 mg) - Certified uranium reference material for the production date

This report describes the development and certification of IRMM-1000a and IRMM-1000b, a uranium reference material certified for the production date based on the 230Th/234U radiochronometer. The certified value was assigned following ISO Guide 34:2009 [ ]. The starting material was low-enriched uranium with a relative mass fraction, m(235U)/m(U) of 3.6%. The chemical separation of the 230Th decay product from its parent nuclide 234U to the maximum extent of completeness was achieved. The certified production date was confirmed using the 230Th/234U radiochronometer, and corresponds to the last chemical separation, i.e. the removal of 230Th from the material to the maximum extent achievable. The between unit-homogeneity and the stability of the certified value were assessed in accordance with ISO Guide 35:2006 [ ]. The material was characterised by taking into account the date and time elapsed of the last chemical and complete separation of 230Th from 234U. The completeness of the separation was confirmed firstly by determining the U/Th separation factors and uranium recoveries using -ray spectrometry, and then by means of ICP-MS measurements using a 232Th tracer. After sufficient ingrowth of thorium into the characterised uranium reference material, measurements of the 234U and the 230Th amount contents were carried out by isotope dilution mass spectrometry (IDMS) in compliance with ISO/IEC 17025:2005 [ ]). Subsequently, the determined n(230Th)/n(234U) was used in the calculation to confirm the certified production date. The uncertainty of the certified value was estimated in compliance with the Guide to the Expression of Uncertainty in Measurement (GUM) [ ] and includes uncertainties related to characterisation, possible inhomogeneity and instability. The material is intended for calibration of methods, quality control, and assessment of method performance with isotope mass spectrometry and radiometry techniques. As any reference material, it can also be used for control charts or validation studies. The certified reference material is available in two sizes: 20 mg (IRMM-1000a) and 50 mg uranium (IRMM-1000b) as dried uranyl nitrate in screw-cap Teflon (PFA) vials. There is no minimum sample intake to be taken into account.JRC.D.2-Standards for Innovation and sustainable Developmen

IRMM-1000a and IRMM-1000b: uranium reference materials certified for the production date based on the 230Th/234U radiochronometer Part II: Certification

The IRMM-1000a and IRMM-1000b uranium reference materials, of 20 mg uranium and 50 mg uranium, respectively, were produced by the European Commission Joint Research Centre’s Institute for Reference Materials and Measurements (EC-JRC-IRMM) in collaboration with the Institute for Transuranium Elements (EC-JRC-ITU). They are the first uranium reference materials certified for the production date based on the 230Th/234U radiochronometer, i.e. the date of the last chemical separation of these two radionuclides. Such certified reference materials (CRMs) are required for proper validation of measurement procedures in Nuclear Forensics in order to determine the "age" of uranium samples and to establish traceability of the measurement results to the SI. The certified reference value and its uncertainty, homogeneity and stability of the material were established in accordance with the ISO Guide 34:2009 and the 'Guide to the Expression of Uncertainty in Measurement'.JRC.D.4-Standards for Nuclear Safety, Security and Safeguard

Quorum Sensing as a Target for Controlling Surface Associated Motility and Biofilm Formation in Acinetobacter Baumannii ATCC® 17978TM

[Abstract] The important nosocomial pathogen Acinetobacter baumannii presents a quorum sensing (QS) system (abaI/abaR) mediated by acyl-homoserine-lactones (AHLs) and several quorum quenching (QQ) enzymes. However, the roles of this complex network in the control of the expression of important virulence-related phenotypes such as surface-associated motility and biofilm formation is not clear. Therefore, the effect of the mutation of the AHL synthase AbaI, and the exogenous addition of the QQ enzyme Aii20J on surface-associated motility and biofilm formation by A. baumannii ATCC® 17978TM was studied in detail. The effect of the enzyme on biofilm formation by several multidrug-resistant A. baumannii clinical isolates differing in their motility pattern was also tested. We provide evidence that a functional QS system is required for surface-associated motility and robust biofilm formation in A. baumannii ATCC® 17978TM. Important differences were found with the well-studied strain A. nosocomialis M2 regarding the relevance of the QS system depending on environmental conditions The in vitro biofilm-formation capacity of A. baumannii clinical strains was highly variable and was not related to the antibiotic resistance or surface-associated motility profiles. A high variability was also found in the sensitivity of the clinical strains to the action of the QQ enzyme, revealing important differences in virulence regulation between A. baumannii isolates and confirming that studies restricted to a single strain are not representative for the development of novel antimicrobial strategies. Extracellular DNA emerges as a key component of the extracellular matrix in A. baumannii biofilms since the combined action of the QQ enzyme Aii20J and DNase reduced biofilm formation in all tested strains. Results demonstrate that QQ strategies in combination with other enzymatic treatments such as DNase could represent an alternative approach for the prevention of A. baumannii colonization and survival on surfaces and the prevention and treatment of infections caused by this pathogen.Xunta de Galicia; ED481A-2015/311Xunta de Galicia; IN606B-2019/010Biotechnology and Biological Sciences Research Council (United Kingdom); BB/R012415/1Xunta de Galicia; ED481A-2019/19

Diversity in Digital Pill Systems: Differences in Perceptions and Attitudes Towards Use of a Digital Pill System for HIV Pre-Exposure Prophylaxis Among Men Who Have Sex With Men with Diverse Racial and Ethnic Identities

Nonadherence, particularly among men who have sex with men (MSM) with substance use disorders increases the risk of both HIV acquisition in those who are uninfected and the risk of disease progression and transmission in those with HIV. Measuring adherence to HIV pre-exposure chemoprophylaxis (PrEP) and antiretroviral therapy (ART), and responding to suboptimal adherence or changes in adherence behavior, remains a challenging public health problem. Despite the importance of accurate adherence measurement, there remains no gold standard for detecting medication ingestion events in HIV research. Technologies have been developed that indirectly infer ingestion events (e.g., via smart pill bottles) or directly measure adherence over periods of time (e.g., via drug concentration in plasma and red blood cells), yet such approaches fail to provide direct confirmation of ingestions and contextual information surrounding adherence and nonadherence. The use of a digital pill system (DPS) – a novel tool that leverages ingestible radiofrequency sensors to measure actual ingestion events – has the potential to advance adherence measurement in HIV research. In this study, we examined the willingness of MSM across racial and ethnic identities to operate a DPS in the context of PrEP adherence measurement and suggest potential future applications of this technology